Tezacaftor

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 336 publications

Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a PBPK modeling approach.

Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a PBPK modeling approach.

Journal: Expert opinion on drug metabolism & toxicology

Published: June 13, 2026

Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

Profiling the CFTR Variant Selectivity and Off-Target Interactions of VX-121.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation.

Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation.

Journal: International journal of molecular sciences

Published: April 28, 2026

ETI corrector therapy suppresses mitochondrial respiration independently of CFTR mutational status.

ETI corrector therapy suppresses mitochondrial respiration independently of CFTR mutational status.

Journal: Biochemical and biophysical research communications

Published: April 10, 2026

Comment on 'Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators'.

Comment on 'Improved Quality of Life in Children With Cystic Fibrosis Who Received Transmembrane Conductance Regulator Modulators'.

Journal: Acta paediatrica (Oslo, Norway : 1992)

Published: March 13, 2026

Smallest Bicycles in Medicinal Chemistry: Where Are We Now?

Smallest Bicycles in Medicinal Chemistry: Where Are We Now?

Journal: Chemical reviews

Published: March 12, 2026

Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis

Evolution of thoracic computed tomography after therapy with elexacaftor, tezacaftor, and ivacaftor in patients with cystic fibrosis

Journal: Revue medicale de Liege

Published: March 12, 2026

Keeping up with CFTR modulator eligibility.

Keeping up with CFTR modulator eligibility.

Journal: Paediatric respiratory reviews

Published: March 10, 2026

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Prenatal Elexacaftor/Tezacaftor/Ivacaftor for Fetal Meconium Ileus: First Italian Case and Narrative Overview of the Emerging Evidence.

Journal: Journal of clinical medicine

Published: February 19, 2026

Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database.

Risk of drug-related aggression in pediatric populations: a pharmacovigilance analysis using the FAERS database.

Journal: Frontiers in pediatrics

Published: February 03, 2026

Development and fit-for-purpose validation of human scalp hair analysis using UHPLC-MS/MS for determining exposure to CFTR modulators.

Development and fit-for-purpose validation of human scalp hair analysis using UHPLC-MS/MS for determining exposure to CFTR modulators.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: February 02, 2026

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Effects of Elexacaftor Tezacaftor Ivacaftor on sinonasal imaging in children with cystic fibrosis.

Journal: Rhinology

Published: February 02, 2026

Showing 1-12 of 336

Last Updated: 06/30/2026